| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 01/01/2018 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/01/2010 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 01/10/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Gunilla Lundmark
BRD | Director/Board Member | 63 | 01/06/2019 |
Denis Angioletti
BRD | Director/Board Member | 58 | 01/01/2020 |
Ola Flink
CHM | Chairman | 82 | 01/01/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -98.73% | - | - | 92.63K | |
| -2.73% | -2.96% | +48.62% | +147.27% | 1,051B | |
| -1.67% | -3.47% | +52.00% | +47.77% | 609B | |
| -0.44% | +2.17% | +33.88% | +78.20% | 450B | |
| -0.75% | +0.30% | +28.32% | +21.15% | 330B | |
| -1.52% | -1.19% | +33.38% | +35.35% | 284B | |
| -1.70% | -1.82% | +20.26% | +15.74% | 263B | |
| -0.58% | +1.11% | -20.89% | -40.59% | 223B | |
| -0.58% | +1.03% | +23.55% | +56.14% | 198B | |
| -0.80% | +1.38% | +23.09% | +66.64% | 167B | |
| Average | -0.68% | -0.16% | +26.91% | +47.52% | 397.23B | |
| Weighted average by Cap. | -0.89% | -1.07% | +35.25% | +70.88% |
Employees
4
Sector
Pharmaceuticals
